Lipocalin 2 orchestrates resistance to ferroptosis via AXL

Authors

• Sabrina Z Wang, Case Western Reserve University
• J Payton Timken, Cleveland Clinic
• Ellen S Hong, Case Western Reserve University
• Sehaj Kaur, Cleveland Clinic
• Eli Newby, Cleveland Clinic
• Kristen E Kay, Cleveland Clinic
• Erin E Mulkearns-Hubert, Case Western Reserve University
• Daniel J Silver, Case Western Reserve University
• Juyeun Lee, Cleveland Clinic
• Joshua B Rubin, Washington University School of Medicine in St. Louis
• James R Connor, Pennsylvania State University
• Loic P Deleyrolle, Mayo Clinic
• Deanna Tiek, Case Western Reserve University
• Andrew Dhawan, Case Western Reserve University
• Justin D Lathia, Case Western Reserve University

Journal

Cell Reports

Publication Date

3-24-2026

Volume

45

Issue

3

First Page

116965

Document Type

Open Access Publication

DOI

10.1016/j.celrep.2026.116965

Rights and Permissions

Wang SZ, Timken JP, Hong ES, Kaur S, Newby E, Kay KE, Mulkearns-Hubert EE, Silver DJ, Lee J, Rubin JB, Connor JR, Deleyrolle LP, Tiek D, Dhawan A, Lathia JD. Lipocalin 2 orchestrates resistance to ferroptosis via AXL. Cell Rep. 2026 Mar 24;45(3):116965. doi: 10.1016/j.celrep.2026.116965. © 2026 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Recommended Citation

Wang, Sabrina Z; Timken, J Payton; Hong, Ellen S; Kaur, Sehaj; Newby, Eli; Kay, Kristen E; Mulkearns-Hubert, Erin E; Silver, Daniel J; Lee, Juyeun; Rubin, Joshua B; Connor, James R; Deleyrolle, Loic P; Tiek, Deanna; Dhawan, Andrew; and Lathia, Justin D, "Lipocalin 2 orchestrates resistance to ferroptosis via AXL." Cell Reports. 45, 3. 116965 (2026).
https://digitalcommons.wustl.edu/oa_4/6738

Department

ICTS (Institute of Clinical and Translational Sciences)

Additional Links

Supplemental material is available for this article at publisher site.